#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Craniopharyngioma Metastatic malignant melanoma Advanced systemic mastocytosis Fusarium infection Systemic lupus erythematosus Primary biliary cholangitis Candida infection Pericarditis General anaesthesia Stiff person syndrome Inclusion body myositis Leukaemia Mitochondrial DNA depletion Haemophagocytic lymphohistiocytosis Urethral valves More trials…

    Learn about Rare Diseases

    Primary immunodeficiency syndrome – Trials in Disease Testicular leiomyosarcoma – Treatment Mastocytosis – Life with Disease Alport’s syndrome – Diagnostics Mantle cell lymphoma stage IV – Basic Information Progressive supranuclear palsy – Diagnostics Mitochondrial myopathy – Diagnostics Arterial tortuosity syndrome – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fremanezumab Pioglitazone Hydrochloride Hydrocortisone Ph. Eur. Loncastuximab Tesirine Encorafenib Acetazolamide Sodium Olopatadine Ropivacaine Atenolol Belantamab Mafodotin Agrostis Stolonifera Pollen Eptacog Alfa (Activated) Neob Remifentanil Opevesostat Cortisone Acetate Andexanet Alfa Barzolvolimab Tradipitant RIMIDUCID More therapies…

    Learn about Your Condition

    Binge eating Eosinophilic gastritis Decreased appetite Type 1 diabetes mellitus Multiple sclerosis relapse Hepatic neoplasm Abortion threatened Leber's congenital amaurosis Aplastic anaemia Deafness Primary hypogonadism Connective tissue disorder Hyperoxaluria Non-Hodgkin's lymphoma C3 glomerulopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prophylaxis of nausea and vomiting

  • A Study to Evaluate LY3537021 and a Drug Combination for Treating Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    • Vomiting
    Investigated Drugs:
    • Ondansetron Hydrochloride
    • LY3537021
    • Aprepitant
    France Italy Romania Spain

  • Study on IV NEPA (Fosnetupitant/Palonosetron) for Preventing Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients

    Recruiting

    4 1 1
    Investigated Drugs:
    • 204-NETU
    • Fosaprepitant
    • Palonosetron Hydrochloride
    Greece Poland Romania

  • Study on Palonosetron and Netupitant for Preventing Nausea in Endometrial Cancer Patients Undergoing Taxane-Platinum Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Dostarlimab
    • Dexamethasone Phosphate
    • Netupitant
    Italy

  • Study of palonosetron and fosaprepitant to prevent nausea and vomiting after laparoscopic surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Fosaprepitant
    • Ondansetron
    • Palonosetron
    Sweden

  • Study on Amisulpride, Dexamethasone Phosphate, and Ondansetron for Preventing Post-Operative Nausea and Vomiting in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Amisulpride
    • Dexamethasone Phosphate
    • Ondansetron
    France Germany

  • Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Fosaprepitant
    • Aprepitant
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!